A systematic review of immune checkpoint inhibitors in endometrial cancer - Top-Institutions - MDSpire

A systematic review of immune checkpoint inhibitors in endometrial cancer

  • By

  • Na Zhu

  • Chaihong Zhang

  • June 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, NY

    Key Differentiators

    • Oncology

  • #4

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

  • #5

    National Human Genome Research Institute
    National Human Genome Research Institute

    Bethesda, MD

    Key Differentiators

    • Oncology

Original Source(s)

A systematic review of immune checkpoint inhibitors in endometrial cancer

  • by Na Zhu, Chaihong Zhang

  • June 8, 2026

Related Content

Association between tumor genomic mutations and the risk of PD-1 inhibitor-induced hypophysitis: a retrospective cohort study

Case Report: a rare case of small cell carcinoma of the prostate

The appearance of “faggot Auer rods” in blasts of non-M3 acute myeloid leukemia